Chaofeng Mu
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Advanced biosensing and bioanalysis techniques 11
- RNA Interference and Gene Delivery 10
- Oncology 14
- Cancer Cells and Metastasis 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Haifa Shen (16 shared papers)Joy Wolfram (11 shared papers)Jianliang Shen (12 shared papers)Junhua Mai (11 shared papers)Dae‐Duk Kim (3 shared papers)Fude Cui (3 shared papers)Yongmei Yin (3 shared papers)Chang‐Koo Shim (2 shared papers)
- Journals
- International Journal of Pharmaceutics (5 papers)Journal of Controlled Release (3 papers)Acta Pharmaceutica Sinica B (2 papers)Biomaterials (2 papers)Mini-Reviews in Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Chaofeng Mu
52 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 110
- Biomaterials 642
- Pharmaceutical Science 273
- Oncology 377
- Molecular Biology 878
- Biomedical Engineering 572
Countries citing papers authored by Chaofeng Mu
This map shows the geographic impact of Chaofeng Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofeng Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofeng Mu more than expected).
Fields of papers citing papers by Chaofeng Mu
This network shows the impact of papers produced by Chaofeng Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofeng Mu. The network helps show where Chaofeng Mu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaofeng Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 268 | |
| 2 | 2010 | 169 | |
| 3 | 2014 | 157 | |
| 4 | 2016 | 131 | |
| 5 | 2017 | 117 | |
| 6 | 2013 | 96 | |
| 7 | 2014 | 95 | |
| 8 | 2015 | 79 | |
| 9 | 2017 | 66 | |
| 10 | 2015 | 60 | |
| 11 | 2017 | 57 | |
| 12 | 2019 | 55 | |
| 13 | 2016 | 52 | |
| 14 | 2017 | 46 | |
| 15 | 2014 | 44 | |
| 16 | 2016 | 42 | |
| 17 | 2020 | 40 | |
| 18 | 2017 | 38 | |
| 19 | 2019 | 35 | |
| 20 | 2021 | 35 |
About Chaofeng Mu
Chaofeng Mu is a scholar working on Molecular Biology, Oncology, Biomaterials, Biomedical Engineering and Hematology, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (11 papers), Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (10 papers), Acute Myeloid Leukemia Research (7 papers), Nanoplatforms for cancer theranostics (7 papers), Advanced Drug Delivery Systems (5 papers), Cancer Cells and Metastasis (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Biomaterials (642 citations), Pharmaceutical Science (273 citations), Oncology (377 citations), Molecular Biology (878 citations) and Biomedical Engineering (572 citations). Chaofeng Mu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Haifa Shen, Joy Wolfram, Jianliang Shen, Junhua Mai, Dae‐Duk Kim, Fude Cui, Yongmei Yin, Chang‐Koo Shim, Suk‐Jae Chung and Zong‐Wan Mao. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Acta Pharmaceutica Sinica B, Biomaterials and Mini-Reviews in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.